135 related articles for article (PubMed ID: 17011694)
1. Relationship between serum human chorionic gonadotrophin levels and body mass index in women undergoing in vitro fertilisation cycles.
Stefanis P; Das S; Barsoum-Derias E; Kingsland C; Lewis-Jones I; Gazvani R
Eur J Obstet Gynecol Reprod Biol; 2007 Jun; 132(2):204-8. PubMed ID: 17011694
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
3. Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles.
Detti L; Mitwally MF; Rode A; Yelian FD; Kruger M; Diamond MP; Puscheck EE
Fertil Steril; 2007 Jul; 88(1):152-5. PubMed ID: 17418834
[TBL] [Abstract][Full Text] [Related]
4. The influence of body mass index to in-vitro fertilisation treatment outcome, risk of miscarriage and pregnancy outcome.
Thum MY; El-Sheikhah A; Faris R; Parikh J; Wren M; Ogunyemi T; Gafar A; Abdalla H
J Obstet Gynaecol; 2007 Oct; 27(7):699-702. PubMed ID: 17999296
[TBL] [Abstract][Full Text] [Related]
5. [Body mass index, protein metabolism profiles and impact on IVF/ICSI procedure and outcome].
Munz W; Fischer-Hammadeh C; Herrmann W; Georg T; Rosenbaum P; Schmidt W; Hammadeh ME
Zentralbl Gynakol; 2005 Feb; 127(1):37-42. PubMed ID: 15702449
[TBL] [Abstract][Full Text] [Related]
6. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
7. Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies.
Bersinger NA; Wunder DM; Nicolas M; Birkhäuser MH; Porquet D; Guibourdenche J
Fetal Diagn Ther; 2008; 24(1):74-8. PubMed ID: 18504387
[TBL] [Abstract][Full Text] [Related]
8. Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization.
Barbieri RL; Sluss PM; Powers RD; McShane PM; Vitonis A; Ginsburg E; Cramer DC
Fertil Steril; 2005 Feb; 83(2):302-8. PubMed ID: 15705366
[TBL] [Abstract][Full Text] [Related]
9. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
[TBL] [Abstract][Full Text] [Related]
10. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
[TBL] [Abstract][Full Text] [Related]
11. Serum resistin level is a predictor of ovarian response in in vitro fertilisation cycle.
Chen YC; Tsai EM; Chen HS; Liu YH; Lee CH; Chou FH; Chen IJ; Chen SY; Jong SB; Chan TF
Acta Obstet Gynecol Scand; 2007; 86(8):963-7. PubMed ID: 17653882
[TBL] [Abstract][Full Text] [Related]
12. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M
Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022
[TBL] [Abstract][Full Text] [Related]
13. GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Engmann L; Benadiva C
Hum Reprod; 2005 Nov; 20(11):3258-60; author reply 3260. PubMed ID: 16246862
[No Abstract] [Full Text] [Related]
14. Human chorionic gonadotropin serum levels following ovulation triggering and IVF cycle outcome.
Mizrachi Y; Horowitz E; Farhi J; Levran D; Raziel A; Weissman A
J Assist Reprod Genet; 2018 May; 35(5):891-897. PubMed ID: 29572693
[TBL] [Abstract][Full Text] [Related]
15. Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study.
Ioannidis G; Sacks G; Reddy N; Seyani L; Margara R; Lavery S; Trew G
Hum Reprod; 2005 Mar; 20(3):741-6. PubMed ID: 15591085
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening.
Bersinger NA; Wunder D; Vanderlick F; Chanson A; Pescia G; Janecek P; Boillat E; Birkhäuser MH
Prenat Diagn; 2004 Jun; 24(6):471-7. PubMed ID: 15229849
[TBL] [Abstract][Full Text] [Related]
17. Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation.
Orvieto R; Zagatsky I; Yulzari-Roll V; La Marca A; Fisch B
Gynecol Endocrinol; 2006 Aug; 22(8):437-40. PubMed ID: 17012105
[TBL] [Abstract][Full Text] [Related]
18. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome.
Rabinson J; Meltcer S; Zohav E; Gemer O; Anteby EY; Orvieto R
Fertil Steril; 2008 Feb; 89(2):472-4. PubMed ID: 17582402
[TBL] [Abstract][Full Text] [Related]
19. Influence of body mass index and self-administration of hCG on the outcome of IVF cycles: a prospective cohort study.
Salha O; Dada T; Sharma V
Hum Fertil (Camb); 2001; 4(1):37-42. PubMed ID: 11591255
[TBL] [Abstract][Full Text] [Related]
20. Early serum beta-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome.
Porat S; Savchev S; Bdolah Y; Hurwitz A; Haimov-Kochman R
Fertil Steril; 2007 Jul; 88(1):82-9. PubMed ID: 17307176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
